Laure, Argie D.

HRN: 05-76-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/05/2025
05/12/2025
IV
500mg
1hr PTOR
Cholelithiasis
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines